Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits. - Wikidata - wikimedia - TriplyDB

Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.

Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.

http://www.wikidata.org/entity/Q37588253

about

Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line.

P2860

Q37615918-EEBC43E9-2F92-49ED-B195-86E944F30C00 Q38704263-D3FDF829-9AF8-4198-B707-A7F152B41D3B

P2860

Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.

http://www.wikidata.org/entity/Q37588253

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Etoposide-Bevacizumab a new st ...... s expressing stem-like traits.

@en

Etoposide-Bevacizumab a new st ...... s expressing stem-like traits.

@nl

type

label

Etoposide-Bevacizumab a new st ...... s expressing stem-like traits.

@en

Etoposide-Bevacizumab a new st ...... s expressing stem-like traits.

@nl

prefLabel

Etoposide-Bevacizumab a new st ...... s expressing stem-like traits.

@en

Etoposide-Bevacizumab a new st ...... s expressing stem-like traits.

@nl

P1433

Q37588253-4BECD873-8280-4265-90BE-750521F1B483

P1476

Q37588253-2CB2D0E2-F357-46B2-9E26-2248B4875272

P2093

Q37588253-20A4B139-595F-4D58-967D-A5739F818D62

Q37588253-35BEFF1B-567A-4F58-890E-CB7F5E5D7438

Q37588253-6184946E-8618-4DED-8DF4-A9B3061E1ACC

Q37588253-8A10C744-FA56-4F9F-9E4B-6EA078133009

Q37588253-F6727D40-4601-4AE8-BC40-DCBFCA7B9669

P2860

Q37588253-01EEF411-0E83-4DB2-B940-3CC1296D7CF6

Q37588253-0A42ADBC-D5CB-4AB3-8446-1C6C7965DD59

Q37588253-170E19A0-BEFE-42C6-B2F8-9E33370F4509

Q37588253-1A4F9A35-5015-4DC8-94E3-7DBACB8A164B

Q37588253-1EF87092-A4A0-444D-A96B-BEEEFA5A35ED

Q37588253-22CA6497-4BFF-4613-8934-B8B08D526CAE

Q37588253-2C2D4D01-09F4-4BA5-89A5-E803CC95ECED

Q37588253-2C39DF3F-8874-46FF-A3BD-E96F9F45E057

Q37588253-2E4F86F6-91D4-4B2D-BD06-E8A95CBF2C95

Q37588253-31FC6EA5-88AE-4DF9-AE01-8CA61AD7C78D

P304

Q37588253-57CC8E4F-A536-4046-BAAB-66733E5FE5B0

P31

Q37588253-3F3B5006-AFC2-4AA3-9CDE-28FE95B05290

P356

Q37588253-3315AF60-A3D5-4586-95C1-0C44361AD2B8

P407

Q37588253-263FDD5A-74F0-477D-8627-CFB5F621D62A

P433

Q37588253-85685B5A-B153-4B01-9BE6-F8F0FA40C00F

P478

Q37588253-3B4A0898-074D-45BD-9849-1EBE8B47C3DD

P50

Q37588253-6F7E8CBE-C82D-4D38-A66E-19089A45469F

Q37588253-7F56E63B-CD02-451C-9CA3-D5BD4F36D352

P577

Q37588253-DBF51AA5-3BB1-4108-A4D8-A3DBDF2463B4

P698

Q37588253-7459EB49-AEA2-45CC-8137-0F7516F56F1B

P921

Q37588253-B4FCEBB8-C2F9-4899-AD73-0C0E5DA08114

P932

Q37588253-0A047627-86E1-4D4C-8709-04CEB3339A41

P356

ONCOTARGET.9939

P1433

P1476

Etoposide-Bevacizumab a new st ...... s expressing stem-like traits.

@en

P2093

Elisa Giannoni

http://www.w3.org/2001/XMLSchema#string

Francesca Bianchini

http://www.w3.org/2001/XMLSchema#string

Maria Letizia Taddei

http://www.w3.org/2001/XMLSchema#string

Maura Calvani

http://www.w3.org/2001/XMLSchema#string

Paola Chiarugi

http://www.w3.org/2001/XMLSchema#string

P2860

Efficient tumour formation by single human melanoma cells

Identification and expansion of human colon-cancer-initiating cells

A tumorigenic subpopulation with stem cell properties in melanomas

Sorafenib in advanced clear-cell renal-cell carcinoma

Time-dependent stabilization of hypoxia inducible factor-1α by different intracellular sources of reactive oxygen species

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Vasculogenic mimicry and tumor angiogenesis.

Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity.

Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells.

Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity

P304

51138-51149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9939

http://www.w3.org/2001/XMLSchema#string

P407

P433

32

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27303923

http://www.w3.org/2001/XMLSchema#string

P921

P932

5239464

http://www.w3.org/2001/XMLSchema#string